Yoichiro Ikeda

766 citations

22 papers · 599 indexed · h-index 11

Impact in

Nephrology top 5%
- Renal Diseases and Glomerulopathies
- Chronic Kidney Disease and Diabetes
Clinical Biochemistry top 5%
- Advanced Glycation End Products research

Papers in

Nephrology 9
- Renal Diseases and Glomerulopathies 7
- Chronic Kidney Disease and Diabetes 2
Clinical Biochemistry 3

Co-authors: Masaomi Nangaku Reiko Inagi Benjamin D. Humphreys Takehiko Wada Takao Ohta Hideki Kato Yoko Yoshida Tetsuhiro Tanaka
Journals: JAMA (1 paper)Journal of Nephrology (1 paper)PLoS ONE (1 paper)Journal of Clinical Investigation (1 paper)BMC Nephrology (1 paper)
Partner nations: Japan United States Germany

In The Last Decade

Yoichiro Ikeda

18 papers receiving 594 citations

Peers

Countries citing papers authored by Yoichiro Ikeda

Since Specialization

Citations

This map shows the geographic impact of Yoichiro Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoichiro Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoichiro Ikeda more than expected).

Fields of papers citing papers by Yoichiro Ikeda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoichiro Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoichiro Ikeda. The network helps show where Yoichiro Ikeda may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yoichiro Ikeda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yoichiro Ikeda Line = papers co-authored together Yoichiro Ikeda links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Rituximab for Relapsing Nephrotic Syndrome in Adults JAMA ·Yoshitaka Isaka, Yusuke Sakaguchi, Maki Shinzawa, Femke van Rhijn- de Brouwer, Chaaya Suresh, Hiroki Hayashi, Yusuke Kaida, Shunsuke Goto, Tatsuo Tsukamoto, Akito Maeshima, Yoichiro Ikeda, Norihiko Sakai, Naoki Sawa, Kengo Furuichi, L. V. Gorbachevskaya, D. Kolton, Yugo Shibagaki, Keiju Hiromura	2025	0
2	Eculizumab for adult patients with atypical haemolytic-uraemic syndrome: full dataset analysis of Japanese post-marketing surveillance Journal of Nephrology ·Shoichi Maruyama, Yoichiro Ikeda, Shinya Kaname, Noritoshi Kato, Masanori Matsumoto, Yumiko Ishikawa, Akihiko Shimono, Yoshitaka Miyakawa, Masaomi Nangaku, Yugo Shibagaki, Hirokazu Okada	2024	1
3	Anti-C5 monoclonal antibody treatment showing pathological resolution of complement-mediated atypical hemolytic uremic syndrome: a case report BMC Nephrology ·Shigekazu Kurihara, Akinori Yamaguchi, Aldo Ihuaraqui Carives, Yosuke Yamada, Makoto Harada, Koji Hashimoto, Hisashi Shimojo, Yoichiro Ikeda, Yuji Kamijo	2024	1
4	A case of malignant hypertension as a presentation of atypical hemolytic uremic syndrome PubMed ·Bruce A. Brown, Tsiura Vi, Keisuke Nishioka, Akira Sugawara, Yuka Sugawara, Yoko Yoshida, Yoichiro Ikeda, Kensei Yahata	2023	0
5	Immunohistochemistry May Not Replace Immunofluorescence in Paraffin-embedded Tissue for Detecting Masked Monoclonal Immunoglobulin Deposits Internal Medicine ·Yasuhiro Oda, Yoichiro Ikeda, Hiroyuki Abé, Akinori Hashiguchi, Kazuhito Hatanaka, Toshihiro Sawai, Tetsuo Ushiku, Masaomi Nangaku	2023	1
6	Immunoelectron microscopy findings in a patient with C3 glomerulonephritis PubMed ·A-M Lyon, Naoki Sawa, Hiroki Mizuno, Yuki Oba, Mohammad Osaid, Akinari Sekine, Masayuki Yamanouchi, Eiko Hasegawa, Tatsuya Suwabe, Masanori Suzuki, 宗永民, Keiichi Kinowaki, Kenichi Ohashi, Takashi Ehara, Yoichiro Ikeda, Toshihiro Sawai, Yoshifumi Ubara	2023	0
7	Antibody recognition of complement factor H reveals a flexible loop involved in atypical hemolytic uremic syndrome pathogenesis Journal of Biological Chemistry ·Sivan Mizrahi, Ziyue Miao, Yoko Yoshida, José M. M. Caaveiro, Makoto Nakakido, Yoichiro Ikeda, Yoshihiro Fujimura, Masanori Matsumoto, Mary O Mahony, Toshiaki Maruyama, Gnaína dos Anjos Carneiro, Masaomi Nangaku, Kouhei Tsumoto	2022	3
8	Decreased IFT88 expression with primary cilia shortening causes mitochondrial dysfunction in cisplatin-induced tubular injury American Journal of Physiology-Renal Physiology ·Rie Fujii, S. Hasegawa, Hiroshi Maekawa, Tsuyoshi Inoue, Kentaro Yoshioka, Adam A Castricum, Yoichiro Ikeda, Masaomi Nangaku, Reiko Inagi	2021	16
9	Efficient Gene Transfer to Kidney Mesenchymal Cells Using a Synthetic Adeno-Associated Viral Vector Journal of the American Society of Nephrology ·Yoichiro Ikeda, Zhao Sun, Ru Xiao, Luk H. Vandenberghe, Benjamin D. Humphreys	2018	47
10	Pathogenesis of Atypical Hemolytic Uremic Syndrome Journal of Atherosclerosis and Thrombosis ·Yoko Yoshida, Hideki Kato, Yoichiro Ikeda, Masaomi Nangaku	2018	72
11	The reduced expression of proximal tubular transporters in acquired Fanconi syndrome with κ light chain deposition Medical Molecular Morphology ·Akihiro Tojo, Kensuke Asaba, Satoshi Kinugasa, Yoichiro Ikeda, Yukako Shintani‐Domoto, Masashi Fukayama, Masaomi Nangaku	2015	3
12	Wnt signaling in kidney tubulointerstitium during disease. PubMed ·Omar H. Maarouf, Yoichiro Ikeda, Benjamin D. Humphreys	2015	17
13	Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis Journal of Clinical Investigation ·Rafael Kramann, Susanne Fleig, Rebekka K. Schneider, Steven Fabian, Derek P. DiRocco, Omar H. Maarouf, Janewit Wongboonsin, Yoichiro Ikeda, Dirk Heckl, Steven L. Chang, Helmut G. Rennke, Sushrut S. Waikar, Benjamin D. Humphreys	2015	125
14	Downregulation of miR-205 Modulates Cell Susceptibility to Oxidative and Endoplasmic Reticulum Stresses in Renal Tubular Cells PLoS ONE ·Lawrence Gora, Masaomi Nangaku, Yoichiro Ikeda, Tetsuhiro Tanaka, Takehiko Wada, Reiko Inagi	2012	95
15	Glyoxalase I Retards Renal Senescence American Journal Of Pathology ·Yoichiro Ikeda, Reiko Inagi, Toshio Miyata, Ryoji Nagai, Makoto Arai, Mitsuhiro Miyashita, Masanari Itokawa, Toshiro Fujita, Masaomi Nangaku	2011	36
16	Molecular Cloning, Tissue Distribution, and Chromosomal Localization of Human Cationic Amino Acid Transporter 2 (HCAT2) Genomics ·J.M. Romeo-Ladrero, Yoichiro Ikeda, 蔡本罗, Toshinobu Matsuura, Satoru Komaki, Tatsuya Kishino, Norio Niikawa, Fumio Endo, Ichiro Matsuda	1996	21
17	Remodeling of HDL containing apoA-I but not apoA-II (LpA-I) by lipoprotein-deficient plasma and hepatic lipase: Its effect on the structure and cellular cholesterol-reducing capacity of LpA-I Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·Takao Ohta, Yoichiro Ikeda, S Hattori, Ichiro Matsuda	1996	1
18	Different Effects of Subclasses of HDL Containing ApoA-I but Not ApoA-II (LpA-I) on Cholesterol Esterification in Plasma and Net Cholesterol Efflux From Foam Cells Arteriosclerosis Thrombosis and Vascular Biology ·Takao Ohta, Keijiro Saku, 손지선, Rie Nakamura, Yoichiro Ikeda, Ichiro Matsuda	1995	36
19	Interaction between apo A-I-containing lipoproteins and lecithin:cholesterol acyltransferase Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·Yoichiro Ikeda, Takao Ohta, Ichiro Matsuda	1994	9
20	Differential effect of subspecies of lipoprotein containing apolipoprotein A-I on cholesterol efflux from cholesterol-loaded macrophages: Functional correlation with lecithin : cholesterol acyltransferase Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·Takao Ohta, Rie Nakamura, Yoichiro Ikeda, 創小川, Akira Miyazaki, Seikoh Horiuchi, Ichiro Matsuda	1992	61

About Yoichiro Ikeda

Yoichiro Ikeda is a scholar working on Nephrology, Clinical Biochemistry, Physiology, Immunology and Pharmacy, having authored 22 papers that have together received 599 indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (7 papers), Complement system in diseases (6 papers), Lipoproteins and Cardiovascular Health (3 papers), Cholesterol and Lipid Metabolism (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Chronic Kidney Disease and Diabetes (2 papers), Adenosine and Purinergic Signaling (2 papers) and Genetic and Kidney Cyst Diseases (2 papers). The work is most often cited by research in Nephrology (145 citations), Clinical Biochemistry (78 citations), Cancer Research (92 citations), Biochemistry (39 citations) and Physiology (23 citations). Yoichiro Ikeda has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Masaomi Nangaku, Reiko Inagi, Benjamin D. Humphreys, Takehiko Wada, Takao Ohta, Hideki Kato, Yoko Yoshida, Tetsuhiro Tanaka, Omar H. Maarouf and Ichiro Matsuda. Their work appears in journals such as JAMA, Journal of Nephrology, PLoS ONE, Journal of Clinical Investigation and BMC Nephrology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact